Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and aspergillosis: recent advances and concepts.
Walsh
T J
TJ
Section of Infectious Diseases, National Cancer Institute, Bethesda, MD 20892.
Van Cutsem
J
J
Polak
A M
AM
Graybill
J R
JR
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000276:immunology / Q000628:therapy*; D002177:Candidiasis / Q000276:immunology / Q000628:therapy*; D004359:Drug Therapy, Combination; D006660:Histoplasmosis / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy
D000935:Antifungal Agents